from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3013/-

LFCtreatmentdescriptionclass of inhibitor

0.896

Amikacinug/mL Amikacintranslation

1.755

Cap5-10ug/mL Capreomycintranslation

2.443

Rox10-50 ug/mL Roxithromycintranslation

0.591

SM2-5 ug/mL Streptomycintranslation

1.452

Tet5-10 ug/mL Tetracyclinetranslation

-0.121

Rif0.2-5ug/mL Rifampicintranscription

0.193

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.245

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.626

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.308

CPZ10-50 ug/mL Chlorpromazinerespiration

-1.231

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.149

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.494

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-1.223

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

1.672

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.220

Econazole10-24 ug/mL Econazole (azole drug)respiration

-1.405

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.395

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-1.370

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.150

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.867

KCN5-20 ug/mL Potassium cyaniderespiration

0.205

NaN30.2-2 mM Sodium aziderespiration

0.620

Nigericin50 uM Nigericinrespiration

-0.256

TRC10-150 ug/mL Triclosanrespiration

-1.710

TRZ10-25 ug/mL Thioridazinerespiration

0.465

Valinomycin0.5-10 uM Valinomycinrespiration

-1.696

ZnSO42 mM ZnSO4respiration

0.151

menadione6-10 ug/mL Menadionerespiration

-0.348

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.005

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.885

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.644

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

1.503

NRP_1Non-replicating persistence stage 1dosRassociated

0.431

Amp0.2mg/mL AmpicillincellWall

0.720

Cephalexin20-100 ug/mL CephalexincellWall

1.097

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.047

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.254

EMB10-20 ug/mL EthambutolcellWall

0.284

Eta12-40 ug/mL EthionamidecellWall

0.611

INH0.2-0.4 ug/mL IsoniazidcellWall

0.319

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.057

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.719

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.357

BZA0.12 mg/mL BenzamidearomaticAmides

-0.617

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.634

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.418

H2O24 mM hydrogen peroxideDNAdamaging

0.513

Levo10 ug/mL LevofloxacinDNAdamaging

-0.262

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.433

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.676

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.539

UVUV-irradiationDNAdamaging

-0.044

ARP41-4 ug/mL Antitubercular compound ARP4?

0.017

Antimycin12.5-50 ug/mL Antimycin A?

0.950

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.774

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.599

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.247

PA8240.2-2 ug/mL PA-824?

-0.578

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.254

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.402

Verapamil50 uM Verapamil?

0.742

mercaptoethanol2 mM 2-Mercaptoethanol?

1.050

methoxatin10-20 ug/mL Methoxatin?